Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05518812
Other study ID # STU00216433
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date July 12, 2022
Est. completion date July 2024

Study information

Verified date November 2023
Source Northwestern University
Contact Magdy P Milad, MD, MS
Phone 312-472-4673
Email mmilad@nm.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to determine if low-dose (i.e., a fraction of what is commonly used) carboprost (Hemabate) helps facilitate fibroid removal (myomectomy).


Description:

Uterine fibroids, also known as leiomyomas, are estimated to affect over 80% of women by the time menopause begins. Many women are asymptomatic and remain undiagnosed, therefore the prevalence of the disease is likely underestimated. Leiomyomas are the most common neoplasms to affect women and can cause morbidities such as heavy menstrual bleeding (HMB) and infertility. According to the American College of Obstetricians and Gynecologists, one-fourth of the women with leiomyomas befit treatment, presenting with heavy or prolonged menstrual bleeding, abdominal protrusion, bowel or bladder dysfunction, infertility, recurrent pregnancy loss, painful menses, or pelvic pain. Risk factors associated with developing leiomyomas include: early menarche, use of oral hormonal contraceptives before the age of 16 years, African descent, and an increased body mass index (BMI) (StatPearls Leiomyoma). Factors that may lower the incidence of leiomyomas include: increased parity, use of depot medroxyprogesterone acetate (DMPA) or oral hormonal contraceptives for any duration. Leiomyomas are benign tumors which arise from monoclonal smooth muscle cells of the uterus (StatPearls Leiomyoma); cells mostly composed of extracellular matrix and encapsulated in a pseudocapsule of areolar tissue. These tumor cells characteristically express higher levels of estrogen and progesterone receptors than normal myometrial cells, and ovarian steroids such as estradiol and progesterone enhance leiomyoma growth. Studies have shown that the size of leiomyomas decrease after menopause when ovarian steroid hormones decline. Leiomyoma cells typically exhibit a low mitotic index. Uterine leiomyomas can impact fertility in multiple ways, for instance, leiomyomas can impede sperm migration, interrupt ovum transport or embryo implantation, and can cause early pregnancy loss. Current treatment options for management of leiomyomas including medical therapies and surgical intervention. Surgically resecting fibroids is one of the most common procedures performed for women of reproductive age. The goal of surgery is to mitigate symptoms and lower the risk of recurrence. Fibroids identified as FIGO 0 or 1 are typically resected completely at hysteroscopy. Unfortunately, fibroids categorized as FIGO 2 when approached hysteroscopically are almost never completely removed given that there can remain residual leiomyoma within the myometrium that is inaccessible. This commonly requires follow up procedures in the coming 6 months as the myometrial portion migrates into the cavity allowing it to be accessible hysteroscopically. Similarly at laparoscopy/laparotomy, FIGO 6 or 7 fibroids are easily resected completely without significant myometrial disruption. In contrast, FIGO 3-5 fibroids require a much more invasive approach into the myometrium, potentially increasing the risk of uterine rupture during pregnancy, a potentially life-threatening event. Techniques have been developed to promote intraoperative fibroid migration towards the access point (laparoscopy/laparotomy/hysteroscopy) with some success. This is a pilot study to determine whether intramural carboprost at low concentrations can facilitate fibroid migration and minimize the risk of carboprost-related side effects. Using carboprost intraoperatively is relatively simple, does not require additional instrumentation, and potentially results in a more complete resection, reducing operative times and re-operation. With the use of carboprost, the myoma is expelled due to the myometrial contraction, and the leiomyoma is shaved down to the myometrium surface, nullifying the need to deeply invade the myometrium.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 2024
Est. primary completion date July 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients scheduled to undergo myomectomy with a surgeon in the division of Minimally Invasive Gynecologic Surgery - Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: - If any oxytocic agents have been or will be administered prior to surgery - History of renal and/or hepatic impairment - Active cardiac disease, pulmonary disease, or pelvic inflammatory disease (PID) - Anemia (Hgb < 7g/dL), diabetes mellitus, jaundice, or epilepsy

Study Design


Intervention

Drug:
Carboprost Tromethamine
During myomectomy, low-dose carboprost will be injected at the base of the fibroid and repeated as necessary. The efficacy of low-dose carboprost is being assessed, and the total dose administered will not exceed single vial for other indications.

Locations

Country Name City State
United States Northwestern University - Northwestern Medicine, Lavin Family Pavilion Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Does instillation of low-dose carboprost facilitate complete resection of FIGO II fibroids during hysteroscopic resection? Pre-operative and post-operative ultrasound will be compared to measure the residual fibroid after hysteroscopic resection with carboprost installation. Pre-operatively to 1 month post-operatively
Secondary To quantitatively assess the efficiency of fibroid resection after carboprost administration by analyzing the video recording from surgery Recordings of all gynecologic surgeries on the site are recorded. The study team members will download and de-identify recordings by removing any PHI and labeling the video with the study ID assigned to the patient by the study team. The video will be used to assess the efficiency of fibroid removal facilitated by low-dose carboprost. The amount of tissue and the time resected will be measured to determine the grams per minute compared to historical controls. Through study completion, up to 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05509244 - Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery N/A
Recruiting NCT04963751 - ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling N/A
Recruiting NCT05125692 - Vaginal Repair of Post Cesarean Istmocele N/A
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Completed NCT06011928 - MOPEXE and RE in Treating Dysmenorrhea N/A
Not yet recruiting NCT05974995 - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer N/A
Completed NCT04839263 - Fast-track in Minimally Invasive Gynaecology N/A
Completed NCT04498208 - Immune Modulation by Enhanced vs Standard Prehabilitation Program Before Major Surgery N/A
Completed NCT04642118 - Low-pressure Pulmonary Recruitment Maneuver to Decrease Post-laparoscopic Shoulder Pain in Gynecologic Surgery N/A
Completed NCT03820115 - Elastic Abdominal Binder After Open Abdominal Surgery for Benign Gynecologic Conditions N/A
Recruiting NCT03327506 - Preoperative Hypnosis Versus Premedication in Gynecological Surgery Phase 4
Recruiting NCT02957500 - To Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) N/A
Completed NCT02476799 - Analgesic Effects of US Bilateral Rectus Sheath Block for Laparoscopic GY Surgery N/A
Recruiting NCT06425484 - The Comparison of Effectiveness Between Epidural Combined Bilateral US TAP Block Versus Epidural Alone for Gynaecology Operation. N/A
Completed NCT02450084 - Ultrasound-guided Bilateral Rectus Sheath Block for Robotic Single-port Gynecologic Surgery N/A
Completed NCT03916445 - Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases
Completed NCT05325619 - Evaluation of the Rate of Consultations in Gynecological Emergencies Under "Non-urgent" Management
Not yet recruiting NCT05781581 - A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection
Recruiting NCT03427840 - Superior Hypogastric Plexus Blockade in Laparoscopic Hysterectomy
Completed NCT03884244 - Postoperative Chewing Gum and Gynecological Laparoscopic Surgery N/A